AR117079A1 - FOXP3 EXPRESSION MODULATORS - Google Patents

FOXP3 EXPRESSION MODULATORS

Info

Publication number
AR117079A1
AR117079A1 ARP190103350A ARP190103350A AR117079A1 AR 117079 A1 AR117079 A1 AR 117079A1 AR P190103350 A ARP190103350 A AR P190103350A AR P190103350 A ARP190103350 A AR P190103350A AR 117079 A1 AR117079 A1 AR 117079A1
Authority
AR
Argentina
Prior art keywords
foxp3 expression
expression modulators
modulators
useful
treating
Prior art date
Application number
ARP190103350A
Other languages
Spanish (es)
Inventor
Susan M Freier
Robert A Macleod
Alexey Revenko
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Publication of AR117079A1 publication Critical patent/AR117079A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las presentes realizaciones proporcionan métodos, compuestos y composiciones útiles para inhibir la expresión de FOXP3, lo que puede ser útil para tratar, prevenir o mejorar el cáncer.The present embodiments provide methods, compounds, and compositions useful for inhibiting FOXP3 expression, which may be useful for treating, preventing, or ameliorating cancer.

ARP190103350A 2018-11-14 2019-11-14 FOXP3 EXPRESSION MODULATORS AR117079A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862767123P 2018-11-14 2018-11-14

Publications (1)

Publication Number Publication Date
AR117079A1 true AR117079A1 (en) 2021-07-07

Family

ID=77369719

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190103350A AR117079A1 (en) 2018-11-14 2019-11-14 FOXP3 EXPRESSION MODULATORS

Country Status (1)

Country Link
AR (1) AR117079A1 (en)

Similar Documents

Publication Publication Date Title
BR112018004620A2 (en) kras expression modulators
CO2017013065A2 (en) Diaciglycerol acyltransferase 2 modulators (dgat2)
ECSP21026021A (en) PNPLA3 EXPRESSION MODULATORS
CR20190471A (en) Modulators of pcsk9 expression
NI202000085A (en) MODULATORS OF APOL1 EXPRESSION
PE20210109A1 (en) IRF4 EXPRESSION MODULATORS
ECSP21053104A (en) HSD17B13 EXPRESSION MODULATORS
CL2021001246A1 (en) Irf5 expression modulators.
CO2020008769A2 (en) Modulators of the dnm2 expression
UY38472A (en) FOXP3 EXPRESSION MODULATORS
CO2020003134A2 (en) Modulators of enac expression
MX2020010721A (en) Modulators of ezh2 expression.
CL2021003442A1 (en) Pharmaceutical composition comprising idelalisib and defactinib; and methods for treating cancer.
AR117079A1 (en) FOXP3 EXPRESSION MODULATORS
UA104340U (en) Composition of smuzi "cheerfulness"